Xylitol Linked to Higher Heart Attack and Stroke Risks

High blood levels of the sugar alcohol xylitol are linked to a 57 per cent greater risk of a heart attack or stroke over a six-year period, according to a recent study presented at the European Society of Cardiology’s annual meeting. Researchers found that this commonly used sweetener, found in diet products, chewing gum, mouthwash, and toothpaste, can accumulate in the bloodstream either through direct ingestion or through the digestion of sugar.

• A recent study presented at the European Society of Cardiology links high blood levels of xylitol to a 57 per cent greater risk of stroke and heart attack over six years.
• Xylitol can accumulate in the bloodstream either by consuming sugar-free or low-calorie products directly or through the natural digestion of sugars.
• Laboratory findings suggest that high concentrations of xylitol and erythritol activate blood platelets, causing them to clump together and form clots.

The Shift in Cardiovascular Risk Perception

For a long time, the dominant risk factors for cardiovascular events have remained a sedentary lifestyle, smoking habits, high blood pressure, high cholesterol, and the progression of ageing. However, research led by Dr Marco Witkowski, a senior cardiology consultant at the Charité University Hospital in Berlin, introduces a new potential contributor in the form of sugar alcohols. The findings made for sober reading because many consumers select xylitol-flavoured products—such as sugar-free jams or yogurts—believing them to be healthier than sugar-laden alternatives.

Dr Witkowski notes that these long-term findings highlight how little is truly known about the cardiovascular safety of xylitol. The substance enters the body through two distinct pathways: direct consumption as a food additive or sweetener, and internal accumulation produced during normal sugar digestion. This dual source complicates dietary assessments for patients managing metabolic or cardiovascular conditions.

Xylitol Mimics Sugar with Fewer Calories

Xylitol is a sugar alcohol, a carbohydrate featuring a chemical structure that mimics both sugars and alcohols to stimulate the tongue’s sweet receptors. Naturally present in small amounts in plants and fungi—including oats, raspberries, strawberries, plums, birch tree bark, and mushrooms—its industrial use has expanded significantly over the past 50 years. Because the human gut only partially absorbs sugar alcohols, xylitol supplies roughly 60 per cent of the calories found in an equivalent amount of table sugar.

This calorie reduction established xylitol, along with related compounds like erythritol, sorbitol, and maltitol, as a staple for the food industry. By 2023, the total global xylitol market reached an estimated valuation of $701.3m (£518.9m). Professor Jürg Beer, a professor at the University of Zurich’s Centre of Molecular Cardiology, points out that the compound occupies a sensitive area in public health. While dentists endorse xylitol for its dental plaque reduction properties in chewing gums, its systemic safety profile now faces renewed scrutiny.

Recent Studies Link Xylitol to Cardiovascular Outcomes

Historically, the clinical perspective on xylitol was largely positive. Prior studies indicated that it could alter the oral microbiome to protect teeth, reduce respiratory infections, and increase beneficial gut chemicals. Because it triggers lower glucose spikes and reduced insulin production compared to sucrose, it gained favour as a weight-loss aid.

Over the past three years, however, research groups including Dr Witkowski and cardiology teams at the Cleveland Clinic published investigations linking xylitol and erythritol to adverse cardiovascular outcomes. These studies associated elevated blood levels of these sugar alcohols with heart attacks and strokes in a cohort of more than 1,100 patients considered at higher risk for cardiovascular disease. Further clinical evaluation involved a human-challenge study where 10 volunteers ingested 30 grams of xylitol—the amount typically contained in a single can of a fizzy drink—followed by blood sampling a half-hour later. The data indicate that these elevated blood concentrations may increase thrombosis risk by activating blood-cell fragments known as platelets, prompting them to clump together. Professor Beer emphasises that these findings regarding sugar alcohols require serious clinical attention.

Recent data from the European Society of Cardiology meeting place this six-year risk increase alongside established lifestyle and metabolic markers.